Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Arrowhead Pharmaceuticals (ARWR) Other Operating Expenses (2016)

Historic Other Operating Expenses for Arrowhead Pharmaceuticals (ARWR) over the last 7 years, with Q4 2016 value amounting to $7.9 million.

  • Arrowhead Pharmaceuticals' Other Operating Expenses rose 1115.75% to $7.9 million in Q4 2016 from the same period last year, while for Sep 2017 it was $7.9 million, marking a year-over-year increase of 30689.63%. This contributed to the annual value of -$3.8 million for FY2016, which is 10926.11% down from last year.
  • According to the latest figures from Q4 2016, Arrowhead Pharmaceuticals' Other Operating Expenses is $7.9 million, which was up 1115.75% from -$26.1 million recorded in Q3 2016.
  • In the past 5 years, Arrowhead Pharmaceuticals' Other Operating Expenses ranged from a high of $47.4 million in Q3 2012 and a low of -$26.1 million during Q3 2016
  • In the last 5 years, Arrowhead Pharmaceuticals' Other Operating Expenses had a median value of $4.8 million in 2014 and averaged $6.2 million.
  • Per our database at Business Quant, Arrowhead Pharmaceuticals' Other Operating Expenses soared by 24822.34% in 2015 and then tumbled by 30738.19% in 2016.
  • Arrowhead Pharmaceuticals' Other Operating Expenses (Quarter) stood at $2.5 million in 2012, then rose by 21.48% to $3.0 million in 2013, then surged by 81.47% to $5.5 million in 2014, then surged by 30.04% to $7.1 million in 2015, then rose by 11.16% to $7.9 million in 2016.
  • Its last three reported values are $7.9 million in Q4 2016, -$26.1 million for Q3 2016, and $7.7 million during Q2 2016.